Yoshifumi Tomii

574 total citations
20 papers, 436 citations indexed

About

Yoshifumi Tomii is a scholar working on Molecular Biology, Organic Chemistry and Pharmacology. According to data from OpenAlex, Yoshifumi Tomii has authored 20 papers receiving a total of 436 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 8 papers in Organic Chemistry and 5 papers in Pharmacology. Recurrent topics in Yoshifumi Tomii's work include Synthesis and biological activity (8 papers), Antibiotics Pharmacokinetics and Efficacy (5 papers) and Antifungal resistance and susceptibility (3 papers). Yoshifumi Tomii is often cited by papers focused on Synthesis and biological activity (8 papers), Antibiotics Pharmacokinetics and Efficacy (5 papers) and Antifungal resistance and susceptibility (3 papers). Yoshifumi Tomii collaborates with scholars based in Japan and Taiwan. Yoshifumi Tomii's co-authors include Masae Sasamoto, Koichi Watanabe, Jiro Fujimoto, Takahiro Matsuki, Masahiro Kise, Satoru Sonoke, Junzo Seki, T Nishino, Hirofumi Makino and Yotaro Kudo and has published in prestigious journals such as Journal of Medicinal Chemistry, Antimicrobial Agents and Chemotherapy and International Journal of Pharmaceutics.

In The Last Decade

Yoshifumi Tomii

19 papers receiving 390 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yoshifumi Tomii Japan 11 211 158 81 65 61 20 436
Sukhraj Kaur India 15 369 1.7× 259 1.6× 42 0.5× 94 1.4× 162 2.7× 52 820
Angela Maione Italy 15 226 1.1× 109 0.7× 45 0.6× 149 2.3× 65 1.1× 43 505
Kamel Alhanout France 10 378 1.8× 258 1.6× 48 0.6× 47 0.7× 55 0.9× 14 832
Azza S. Zakaria Egypt 13 97 0.5× 85 0.5× 32 0.4× 45 0.7× 101 1.7× 31 371
Diego Romário Silva Brazil 11 176 0.8× 197 1.2× 34 0.4× 150 2.3× 33 0.5× 31 532
Rajendra Prasad India 10 173 0.8× 63 0.4× 50 0.6× 142 2.2× 46 0.8× 19 433
Momen Askoura Egypt 17 382 1.8× 123 0.8× 55 0.7× 118 1.8× 61 1.0× 33 726
Chenzhong Fei China 16 174 0.8× 60 0.4× 25 0.3× 31 0.5× 104 1.7× 53 632
Ramin Abiri Iran 18 283 1.3× 152 1.0× 21 0.3× 136 2.1× 83 1.4× 72 769
Nadine A. Schilling Germany 7 511 2.4× 162 1.0× 177 2.2× 201 3.1× 57 0.9× 10 892

Countries citing papers authored by Yoshifumi Tomii

Since Specialization
Citations

This map shows the geographic impact of Yoshifumi Tomii's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yoshifumi Tomii with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yoshifumi Tomii more than expected).

Fields of papers citing papers by Yoshifumi Tomii

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yoshifumi Tomii. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yoshifumi Tomii. The network helps show where Yoshifumi Tomii may publish in the future.

Co-authorship network of co-authors of Yoshifumi Tomii

This figure shows the co-authorship network connecting the top 25 collaborators of Yoshifumi Tomii. A scholar is included among the top collaborators of Yoshifumi Tomii based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yoshifumi Tomii. Yoshifumi Tomii is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Watanabe, Koichi, Jiro Fujimoto, Yoshifumi Tomii, et al.. (2009). Lactobacillus kisonensis sp. nov., Lactobacillus otakiensis sp. nov., Lactobacillus rapi sp. nov. and Lactobacillus sunkii sp. nov., heterofermentative species isolated from sunki, a traditional Japanese pickle. INTERNATIONAL JOURNAL OF SYSTEMATIC AND EVOLUTIONARY MICROBIOLOGY. 59(4). 754–760. 48 indexed citations
2.
Chao, Shiou-Huei, Yoshifumi Tomii, Masae Sasamoto, et al.. (2008). Lactobacillus capillatus sp. nov., a motile bacterium isolated from stinky tofu brine. INTERNATIONAL JOURNAL OF SYSTEMATIC AND EVOLUTIONARY MICROBIOLOGY. 58(11). 2555–2559. 31 indexed citations
3.
Fujimoto, Jiro, Takahiro Matsuki, Masae Sasamoto, Yoshifumi Tomii, & Koichi Watanabe. (2008). Identification and quantification of Lactobacillus casei strain Shirota in human feces with strain-specific primers derived from randomly amplified polymorphic DNA. International Journal of Food Microbiology. 126(1-2). 210–215. 94 indexed citations
4.
Fukui, Hiroshi, Tomohiro Koike, Takashi Nakagawa, et al.. (2003). Comparison of LNS-AmB, a novel low-dose formulation of amphotericin B with lipid nano-sphere (LNS®), with commercial lipid-based formulations. International Journal of Pharmaceutics. 267(1-2). 101–112. 42 indexed citations
5.
Tomii, Yoshifumi. (2002). Lipid Formulation as a Drug Carrier for Drug Delivery. Current Pharmaceutical Design. 8(6). 467–474. 46 indexed citations
6.
Matsuoka, Masato, et al.. (1999). Synthesis and Antibacterial Activity of Novel 7-Substituted-6-fluoro-1-fluoromethyl-4-oxo-4H-(1,3)thiazeto (3,2-.ALPHA.)quinoline-3-carboxylic Acid Derivatives.. Chemical and Pharmaceutical Bulletin. 47(12). 1765–1773. 10 indexed citations
7.
8.
Maesaki, Shigefumi, Mohammad Ashraf Hossain, Yoshihiro Yamamoto, et al.. (1999). In Vitro and In Vivo Activities of NS-718, a New Lipid Nanosphere Incorporating Amphotericin B, against Aspergillus fumigatus. Antimicrobial Agents and Chemotherapy. 43(3). 471–475. 29 indexed citations
9.
Tomii, Yoshifumi, et al.. (1997). In vivo Antibacterial Activity of a Prodrug of NM394, a Thiazetoquinoline Carboxylic Acid Derivative. Chemotherapy. 44(1). 21–30. 3 indexed citations
10.
Tomii, Yoshifumi, et al.. (1996). Structure-Antibacterial Activity and Cytotoxicity Relationships of Thiazolo and Thiazetoquinolone Derivatives.. Biological and Pharmaceutical Bulletin. 19(11). 1457–1462. 6 indexed citations
11.
Tomii, Yoshifumi, et al.. (1996). Uptake and intracellular activity of NM394, a new quinolone, in human polymorphonuclear leukocytes. Antimicrobial Agents and Chemotherapy. 40(3). 739–742. 16 indexed citations
12.
Tomii, Yoshifumi, et al.. (1996). Therapeutic effect of the quinolone prodrug prulifloxacin against experimental urinary tract infections in mice.. PubMed. 46(12). 1169–73. 6 indexed citations
13.
14.
15.
Matsuoka, Masato, et al.. (1992). Studies on pyridonecarboxylic acids. 1. Synthesis and antibacterial evaluation of 7-substituted-6-halo-4-oxo-4H-[1,3]thiazeto[3,2-a]quinoline-3-carboxylic acids. Journal of Medicinal Chemistry. 35(25). 4727–4738. 31 indexed citations
16.
Tomii, Yoshifumi, Kiyoshi Kimura, Masahiro Kise, et al.. (1992). In Vivo Evaluation of NM441, a New Thiazeto-Quinoline Derivative. Antimicrobial Agents and Chemotherapy. 36(5). 1170–1170. 1 indexed citations
17.
Tomii, Yoshifumi, Kiyoshi Kimura, Masahiro Kise, et al.. (1992). In Vitro Antibacterial Activity of a New Quinolone, NM394. Antimicrobial Agents and Chemotherapy. 36(5). 1170–1170. 3 indexed citations
18.
Tomii, Yoshifumi, Kiyoshi Kimura, Jiro Segawa, et al.. (1991). In vivo evaluation of NM441, a new thiazeto-quinoline derivative. Antimicrobial Agents and Chemotherapy. 35(12). 2496–2499. 31 indexed citations
19.
Tomii, Yoshifumi, Kiyoshi Kimura, Masahiro Kise, et al.. (1991). In vitro antibacterial activity of a new quinolone, NM394. Antimicrobial Agents and Chemotherapy. 35(12). 2490–2495. 24 indexed citations
20.
Tomii, Yoshifumi, et al.. (1984). A case of malignant melanoma of the ovary discovered by endometrial aspiration smear.. The Journal of the Japanese Society of Clinical Cytology. 23(4). 615–621. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sukhraj Kaur Breakdown of academic impact, for papers by Angela Maione Breakdown of academic impact, for papers by Kamel Alhanout Breakdown of academic impact, for papers by Azza S. Zakaria Breakdown of academic impact, for papers by Diego Romário Silva Breakdown of academic impact, for papers by Rajendra Prasad Breakdown of academic impact, for papers by Momen Askoura Breakdown of academic impact, for papers by Chenzhong Fei Breakdown of academic impact, for papers by Ramin Abiri Breakdown of academic impact, for papers by Nadine A. Schilling
Rankless by CCL
2026